A clinical study comparing remimazolam and propofol during laparoscopic cholecystectomy.

Comparison of efficacy and safety remimazolam and propofol during laparoscopic cholecystectomy.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0006702

Enrollment

108

Registered

2021-11-04

Start date

2021-10-19

Completion date

Unknown

Last updated

2021-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : For anesthesia induction, remimazolam 0.2mg/kg and propofol 2mg/kg are injected IV as bolus. Immediately after intubation, anesthesia is maintained by IV infusion with remimazolam 0.15 mg/kg a

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ? American Society of Anesthesiologists body classification I, II, or III ? Patients over the age of 19 who agreed to participate in the study ? Elective laparoscopic cholecystectomy performed at our hospital

Exclusion criteria

Exclusion criteria: ? In case of previous hepatectomy or liver transplant ? In case of uncontrolled hypertension (systolic blood pressure=180 mmHg) ? When BMI = 35 ? If you have previously experienced side effects due to general or local anesthesia drugs

Design outcomes

Primary

Measure	Time frame
Time from anesthesia induction to MOAA/S score of 2; Time from infusion stop to eye opening;Time from infusion stop to spontaneous respiration; Time from infusion stop to extubation	—

Secondary

Measure	Time frame
hemodynamic changes; Degree of pain during drug injection;Time until modified Aldrete score of 9 after discontinuation of drug infusion	—

Countries

Korea, Republic of

Contacts

Public ContactTae Young Lee

Dong-A University Hospital

pinpd@naver.com+82-51-240-5390

Outcome results